Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 429,202 | 476,124 | 299,521 | 394,796 | 389,578 |
| Receivables | 2,255 | 2,526 | 2,599 | 3,094 | 3,164 |
| Other current assets | 42,715 | 43,725 | 41,495 | 40,247 | 17,780 |
| TOTAL | $474,172 | $522,375 | $343,615 | $438,137 | $410,522 |
| Non-Current Assets | |||||
| PPE Net | 84,410 | 83,633 | 86,716 | 86,510 | 86,248 |
| Intangibles | 86,149 | 90,266 | 85,132 | 88,499 | 92,209 |
| Other Non-Current Assets | 81,768 | 79,587 | 42,384 | 40,553 | 41,846 |
| TOTAL | $252,327 | $253,486 | $214,232 | $215,562 | $220,303 |
| Total Assets | $726,499 | $775,861 | $557,847 | $653,699 | $630,825 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,260 | 3,762 | 5,115 | 3,953 | 4,265 |
| Accrued Expenses | 40,597 | 33,401 | 26,070 | 46,635 | 39,806 |
| Other current liabilities | 49,579 | 32,204 | 36,618 | 36,426 | 43,997 |
| TOTAL | $108,888 | $86,083 | $73,920 | $93,171 | $94,118 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,510 | 22,921 | 1,071 | 1,101 | 1,126 |
| Other Non-Current Liabilities | 72,374 | 82,408 | 81,177 | 94,652 | 95,683 |
| TOTAL | $93,052 | $105,329 | $82,776 | $97,092 | $98,740 |
| Total Liabilities | $201,940 | $191,412 | $156,696 | $190,263 | $192,858 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 286,641 | 281,109 | 237,664 | 234,653 | 216,623 |
| Common Shares | 3 | 3 | 2 | 2 | 2 |
| Retained earnings | -1,252,377 | -1,156,535 | -1,058,995 | -967,622 | -874,626 |
| TOTAL | $524,559 | $584,449 | $401,151 | $463,436 | $437,967 |
| Total Liabilities And Equity | $726,499 | $775,861 | $557,847 | $653,699 | $630,825 |